Benefit of cervical screening at different ages: evidence from the UK audit of screening histories View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-07

AUTHORS

P Sasieni, J Adams, J Cuzick

ABSTRACT

While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20-69 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55-69 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40-54 years, but is almost as good as annual screening (88%). In women aged 20-39 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women. British Journal of Cancer (2003) 89, 88-93. doi:10.1038/sj.bjc.6600974 www.bjcancer.com More... »

PAGES

88

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974

DOI

http://dx.doi.org/10.1038/sj.bjc.6600974

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044836408

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12838306


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Policy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Audit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical History Taking", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginal Smears", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research UK", 
          "id": "https://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sasieni", 
        "givenName": "P", 
        "id": "sg:person.01257735610.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735610.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research UK", 
          "id": "https://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adams", 
        "givenName": "J", 
        "id": "sg:person.01116172313.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116172313.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research UK", 
          "id": "https://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cuzick", 
        "givenName": "J", 
        "id": "sg:person.01136740201.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136740201.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2303.2000.00269.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002995103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.1546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009171682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2303.2001.00288.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029566248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.293.6548.659", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030672743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)04646-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037908433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1996.196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056443386", 
          "https://doi.org/10.1038/bjc.1996.196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1996.196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056443386", 
          "https://doi.org/10.1038/bjc.1996.196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082220600", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-07", 
    "datePublishedReg": "2003-07-01", 
    "description": "While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20-69 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55-69 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40-54 years, but is almost as good as annual screening (88%). In women aged 20-39 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women. British Journal of Cancer (2003) 89, 88-93. doi:10.1038/sj.bjc.6600974 www.bjcancer.com", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6600974", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "89"
      }
    ], 
    "name": "Benefit of cervical screening at different ages: evidence from the UK audit of screening histories", 
    "pagination": "88", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d591f2ceec75c4a0bc82be751bfdd61bcee6f774ecadc499f5807032affda189"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12838306"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600974"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044836408"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600974", 
      "https://app.dimensions.ai/details/publication/pub.1044836408"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29191_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6600974"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      21 PREDICATES      53 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600974 schema:about N02cf99a898df40dea9689edf6972f219
2 N0defcf273d1d4a54a9388bec1f2ecadb
3 N3e8132ae880744449155c2db420319a3
4 N3f8c30857d2a4a4c8f960423ecfc4883
5 N5fedab2e123547ab8337dfb56bf57b25
6 N691c0d820d6240f5a1aa5bbcfa24f1cd
7 N6bb946191bb64875894db11aff3082ea
8 N74c624603b2c493face616354826e483
9 N7a0e33d8bdbc469a8a5ab56fcd13f330
10 N7c78be5b0c3a4a56933dcb753dfe117c
11 Nab1f22b0003743a1bd970f19c1599612
12 Nae8d7c39cff54d17bd968158a5b58032
13 Nb9c67a4b68cf4f2a990af749454ffb3c
14 Nc73330070f484db6986b9f2dd4d7a8b4
15 Ndc6677e95e76420f8ad867d9f3c002a6
16 Nf517d73184964810b0558ae43ed55b4e
17 Nfe044ca3c339448380ceb96c5ad9db6d
18 anzsrc-for:11
19 anzsrc-for:1117
20 schema:author N74cd5db94c994ae4a7561906a933bc3b
21 schema:citation sg:pub.10.1038/bjc.1996.196
22 https://app.dimensions.ai/details/publication/pub.1082220600
23 https://doi.org/10.1002/ijc.1546
24 https://doi.org/10.1016/s0140-6736(00)04646-8
25 https://doi.org/10.1046/j.1365-2303.2000.00269.x
26 https://doi.org/10.1046/j.1365-2303.2001.00288.x
27 https://doi.org/10.1136/bmj.293.6548.659
28 schema:datePublished 2003-07
29 schema:datePublishedReg 2003-07-01
30 schema:description While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20-69 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55-69 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40-54 years, but is almost as good as annual screening (88%). In women aged 20-39 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women. British Journal of Cancer (2003) 89, 88-93. doi:10.1038/sj.bjc.6600974 www.bjcancer.com
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N3010377188a9458589c8dee3585a7eb8
35 Ndb42765b53bd4deda55ca108f146cb0f
36 sg:journal.1017082
37 schema:name Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
38 schema:pagination 88
39 schema:productId N6babae7af6464210b7d33e9bfa16edaf
40 N6fffbbf06eed4347a0f19992be7950c0
41 N7b65f873495d46c7b65355b0aed339c6
42 N7e85a28efecc41f1910edf53b6bff8b6
43 N8f7b6a6969144c9e882831f723d5fa3d
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044836408
45 https://doi.org/10.1038/sj.bjc.6600974
46 schema:sdDatePublished 2019-04-11T11:52
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N72b477cabfcf491c994d6d9e2f3b9577
49 schema:url https://www.nature.com/articles/6600974
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N02cf99a898df40dea9689edf6972f219 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Neoplasm Invasiveness
55 rdf:type schema:DefinedTerm
56 N0defcf273d1d4a54a9388bec1f2ecadb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Adult
58 rdf:type schema:DefinedTerm
59 N1014dac041014412b6febf558de76f3f rdf:first sg:person.01136740201.43
60 rdf:rest rdf:nil
61 N3010377188a9458589c8dee3585a7eb8 schema:issueNumber 1
62 rdf:type schema:PublicationIssue
63 N3e8132ae880744449155c2db420319a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Aged
65 rdf:type schema:DefinedTerm
66 N3f8c30857d2a4a4c8f960423ecfc4883 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Middle Aged
68 rdf:type schema:DefinedTerm
69 N5fedab2e123547ab8337dfb56bf57b25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Female
71 rdf:type schema:DefinedTerm
72 N691c0d820d6240f5a1aa5bbcfa24f1cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Health Policy
74 rdf:type schema:DefinedTerm
75 N6babae7af6464210b7d33e9bfa16edaf schema:name dimensions_id
76 schema:value pub.1044836408
77 rdf:type schema:PropertyValue
78 N6bb946191bb64875894db11aff3082ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name United Kingdom
80 rdf:type schema:DefinedTerm
81 N6fffbbf06eed4347a0f19992be7950c0 schema:name pubmed_id
82 schema:value 12838306
83 rdf:type schema:PropertyValue
84 N72b477cabfcf491c994d6d9e2f3b9577 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N74c624603b2c493face616354826e483 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Medical History Taking
88 rdf:type schema:DefinedTerm
89 N74cd5db94c994ae4a7561906a933bc3b rdf:first sg:person.01257735610.85
90 rdf:rest Nf32d32a539ab4d5ca60a79966c214e9c
91 N7a0e33d8bdbc469a8a5ab56fcd13f330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Databases, Factual
93 rdf:type schema:DefinedTerm
94 N7b65f873495d46c7b65355b0aed339c6 schema:name readcube_id
95 schema:value d591f2ceec75c4a0bc82be751bfdd61bcee6f774ecadc499f5807032affda189
96 rdf:type schema:PropertyValue
97 N7c78be5b0c3a4a56933dcb753dfe117c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Case-Control Studies
99 rdf:type schema:DefinedTerm
100 N7e85a28efecc41f1910edf53b6bff8b6 schema:name doi
101 schema:value 10.1038/sj.bjc.6600974
102 rdf:type schema:PropertyValue
103 N8f7b6a6969144c9e882831f723d5fa3d schema:name nlm_unique_id
104 schema:value 0370635
105 rdf:type schema:PropertyValue
106 Nab1f22b0003743a1bd970f19c1599612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 Nae8d7c39cff54d17bd968158a5b58032 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Uterine Cervical Neoplasms
111 rdf:type schema:DefinedTerm
112 Nb9c67a4b68cf4f2a990af749454ffb3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Practice Guidelines as Topic
114 rdf:type schema:DefinedTerm
115 Nc73330070f484db6986b9f2dd4d7a8b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Medical Audit
117 rdf:type schema:DefinedTerm
118 Ndb42765b53bd4deda55ca108f146cb0f schema:volumeNumber 89
119 rdf:type schema:PublicationVolume
120 Ndc6677e95e76420f8ad867d9f3c002a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Vaginal Smears
122 rdf:type schema:DefinedTerm
123 Nf32d32a539ab4d5ca60a79966c214e9c rdf:first sg:person.01116172313.51
124 rdf:rest N1014dac041014412b6febf558de76f3f
125 Nf517d73184964810b0558ae43ed55b4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Mass Screening
127 rdf:type schema:DefinedTerm
128 Nfe044ca3c339448380ceb96c5ad9db6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Age Factors
130 rdf:type schema:DefinedTerm
131 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
132 schema:name Medical and Health Sciences
133 rdf:type schema:DefinedTerm
134 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
135 schema:name Public Health and Health Services
136 rdf:type schema:DefinedTerm
137 sg:journal.1017082 schema:issn 0007-0920
138 1532-1827
139 schema:name British Journal of Cancer
140 rdf:type schema:Periodical
141 sg:person.01116172313.51 schema:affiliation https://www.grid.ac/institutes/grid.11485.39
142 schema:familyName Adams
143 schema:givenName J
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116172313.51
145 rdf:type schema:Person
146 sg:person.01136740201.43 schema:affiliation https://www.grid.ac/institutes/grid.11485.39
147 schema:familyName Cuzick
148 schema:givenName J
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136740201.43
150 rdf:type schema:Person
151 sg:person.01257735610.85 schema:affiliation https://www.grid.ac/institutes/grid.11485.39
152 schema:familyName Sasieni
153 schema:givenName P
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735610.85
155 rdf:type schema:Person
156 sg:pub.10.1038/bjc.1996.196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056443386
157 https://doi.org/10.1038/bjc.1996.196
158 rdf:type schema:CreativeWork
159 https://app.dimensions.ai/details/publication/pub.1082220600 schema:CreativeWork
160 https://doi.org/10.1002/ijc.1546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009171682
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s0140-6736(00)04646-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037908433
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1046/j.1365-2303.2000.00269.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002995103
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1046/j.1365-2303.2001.00288.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029566248
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1136/bmj.293.6548.659 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030672743
169 rdf:type schema:CreativeWork
170 https://www.grid.ac/institutes/grid.11485.39 schema:alternateName Cancer Research UK
171 schema:name Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...